2017 Fiscal Year Final Research Report
Global analysis of cancer-tissue-derived microRNA to improve treatment outcome of cancer of unknown primary
| Project/Area Number |
15K08640
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Laboratory medicine
|
|---|
| Research Institution | University of Tsukuba |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
小島 寛 筑波大学, 医学医療系, 教授 (10225435)
島居 徹 筑波大学, 医学医療系, 教授 (80235613)
玉木 義雄 筑波大学, 医学医療系, 教授 (60188422)
沖 明典 筑波大学, 医学医療系, 教授 (60334067)
鈴木 久史 筑波大学, 医学医療系, 講師 (40750740)
|
|---|
| Research Collaborator |
INADA Katsushige
|
|---|
| Project Period (FY) |
2015-04-01 – 2018-03-31
|
| Keywords | 原発不明がん / マイクロRNA / 原発組織 / ホルマリン固定パラフィン包埋 / リンパ節 / 内在性コントロール遺伝子 |
|---|
| Outline of Final Research Achievements |
To assess the primary tumor of metastatic lesion, we investigated microRNA (miRNA) expression patterns using formalin-fixed, paraffin-embedded (FFPE) lymph node tissues. Initial analysis of 31 samples from 11 types of tumor resulted that the primary site was correctly predicted in 71 %. To achieve higher accuracy, we noticed that an endogenous reference gene for miRNA expression analysis had not been identified in FFPE lymph node with metastatic cancer. A suitable endogenous reference gene should be evaluated to avoid misinterpretation of data and identify true changes in miRNA expression levels. Finally, we found that the combination of three miRNAs, miR-24/miR-103a/let-7a, could be used as a suitable endogenous reference in a lymph node with metastatic cancer.
|
| Free Research Field |
医学 血液内科
|
